GRAIL (MEX:GRAL) Debt-to-Equity : 0.03 (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is GRAIL Debt-to-Equity?

GRAIL's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was MXN266 Mil. GRAIL's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was MXN1,155 Mil. GRAIL's Total Stockholders Equity for the quarter that ended in Sep. 2024 was MXN50,951 Mil. GRAIL's debt to equity for the quarter that ended in Sep. 2024 was 0.03.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for GRAIL's Debt-to-Equity or its related term are showing as below:

MEX:GRAL' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.03 Med: 0.02 Max: 0.03
Current: 0.03

During the past 4 years, the highest Debt-to-Equity Ratio of GRAIL was 0.03. The lowest was -0.03. And the median was 0.02.

MEX:GRAL's Debt-to-Equity is ranked better than
88.48% of 191 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.27 vs MEX:GRAL: 0.03

GRAIL Debt-to-Equity Historical Data

The historical data trend for GRAIL's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Debt-to-Equity Chart

GRAIL Annual Data

Trend

Dec18

Dec19

Dec22

Dec23

Debt-to-Equity

-0.03

0.02

GRAIL Quarterly Data
	Dec18	Jun19	Dec19	Jun20	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial							N/A	0.02	0.02	0.03	0.03

Competitive Comparison of GRAIL's Debt-to-Equity

For the Diagnostics & Research subindustry, GRAIL's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GRAIL's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GRAIL's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where GRAIL's Debt-to-Equity falls into.

GRAIL Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

GRAIL's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(251.372	+	1181.374)	/	61891.282
	=	0.02

GRAIL's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(266.292	+	1155.171)	/	50951.329
	=	0.03

GRAIL (MEX:GRAL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

GRAIL Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of GRAIL's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

GRAIL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (MEX:GRAL) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

GRAL:USA NL0:Germany

Address

1525 O’Brien Drive, Menlo Park, CA, USA, 94025

Website

https://www.grail.com

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.